Predictive biomarkers and pharmacodynamics of PI3K/AKT/mTOR inhibitors

Date 01 March 2014
Event Signalling Pathways in Cancer 2014
Session Clinical development of PI3K/AKT/mTOR inhibitors
Topics Drug Development
Translational Research
Presenter Johann de Bono
Authors J.S. de Bono
  • Royal Marsden Hospital, The Institute of Cancer Research, Sutton/UK